Stock News

Unlocking the Power of AI: How AvePoint is Revolutionizing SaaS Data Management Description AvePoint offers comprehensive SaaS-based data management solutions that are gaining relevance with the AI revolution. Their services address critical aspects of data management such as security, storage optimization, and productivity enhancement. The company has a high-margin recurring revenue of 87%, impressive customer…

Welcome to the Retail Rollercoaster! What’s Up with B&M European Value Retail SA? So, word on the street is that B&M European Value Retail SA just got downgraded to ‘sell’. Well, that’s a bummer. But hey, it happens. Sometimes stocks go up, sometimes they go down. It’s all part of the game, right? Marks and…

Fun with Functional Mushrooms and Psilocybin Truffles! Get Ready for a Trip with Red Light Holland Corp. Exciting News from Red Light Holland Corp. Hey there, mushroom enthusiasts and psychedelic adventurers! Red Light Holland Corp. is here to spice up your life with some exciting updates and a live Q&A session that you won’t want…

Amprius Technologies Receives Contracts for High-Performance Cells Clever, Personable, Unconventional, and Reader-Friendly Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX) has recently announced that it has secured two contracts to supply 40 Ah high-performance cells for Light Electric Vehicle (“LEV”) applications. The total value of these contracts exceeds $20 million, showcasing Amprius’ expertise in…

Welcome to the Jackpot Digital Inc. Blog! A Fifth Amendment Agreement for Jackpot Digital Inc. Vancouver, British Columbia–(Newsfile Corp. – September 23, 2024) Jackpot Digital Inc. (TSXV: JJ) (TSXV: JJ.WT.B) (TSXV: JJ.WT.C) (OTCQB: JPOTF) (FSE: LVH3) (the “Company” or “Jackpot”) is pleased to announce that further to its news release dated July 10, 2023, the…

ORYZON Unveils Groundbreaking Findings from PORTICO: A Global Phase IIb Vafidemstat Trial for Borderline Personality Disorder (BPD) at the European College of Neuropsychopharmacology (ECNP) Conference Madrid and Cambridge, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet…

Welcome to the Future of Clean Energy Training Exciting Collaboration for ReElement Technologies Are you ready to dive into the world of clean energy and material processing? Well, you’re in luck! ReElement Technologies Corporation, a leading provider in refining rare earth and critical battery elements, has just announced a groundbreaking collaboration with Ivy Tech Community…

Breaking Boundaries: Alterity Therapeutics to Showcase Groundbreaking Research at the International Congress of Parkinson’s Disease and Movement Disorders Description: Late Breaking Abstract and Oral Presentation on ATH434-202 Interim Phase 2 Data Oral Presentation on ATH434-201 Phase 2 Baseline Characteristics MELBOURNE, Australia and SAN FRANCISCO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ:…